Skip Navigation

Advertise|Press|Contact|FAQ|About Us


Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology | Family Medicine
Disease Category: High Blood Pressure (Hypertension)
Location: United States, CA

Clinical Trial Details


Research Study Summary

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose


Blood Pressure and Metabolic Effects of Nebivolol Compared with Hydrochlorothiazide and Placebo in Hypertensive patients with Impaired Glucose Tolerance or Impaired Fasting Glucose.

Inclusion Criteria:

  • Male or female, ambulatory outpatients 18-80 years old at screening.
  • Have a history of hypertension
  • Qualifying laboratory results

Exclusion Criteria:

  • Severe Hypertension, including chronic renal disease
  • Use of niacin or anti-diabetic medication (oral or injectable) within 6 months of study
  • Have clinically significant respiratory, liver, or cardiovascular disease
  • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates
  • Have a history of hypersensitivity to nebivolol, other beta-blockers, or other sulfonomide-derived drugs.

To Learn more



Both Male and Female


18 to 80 Years

Overall Status


Facility Type



Diablo Clinical Research
1365 Corte Loma
Walnut Creek, CA 94598
Phone: 925-930-7267
Fax: 925-930-7392

View Map

Research Center Information: Diablo Clinical Research

CW ID: 157673

Date Last Changed: July 24, 2013

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.